Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors
NCT00143533
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Neoplasm
Diarrhea
Interventions
DRUG:
Irinotecan, Cefpodoxime
Sponsor
St. Jude Children's Research Hospital
Collaborators
[object Object]